Medivir AB (MVR0) Financial Statements

0 Followers

Medivir AB Financial Overview

Medivir AB's market cap is currently €110.63M. The company's EPS TTM is €-0.0031707200000000006; its P/E ratio is -4.59; Medivir AB is scheduled to report earnings on August 20, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Income Statement
Total Revenue
Gross Profit	-	-	$ 13.95M	-	-
Operating Income	$ -88.61M	$ -64.40M	$ -55.68M	$ -128.59M	$ -351.03M
EBITDA	$ -85.27M	$ -59.03M	$ -37.64M	$ -114.93M	$ -324.16M
Net Income	$ -88.77M	$ -63.13M	$ -42.62M	$ -123.44M	$ -350.31M
Balance Sheet
Cash & Short-Term Investments	$ ―	$ ―	$ ―	$ ―	$ ―
Total Assets	$ 234.20M	$ 335.82M	$ 191.46M	$ 293.46M	$ 419.35M
Total Debt	$ 15.51M	$ 14.02M	$ 16.49M	$ 43.88M	$ 0.00
Net Debt	$ -101.92M	$ -207.15M	$ -53.52M	$ -90.63M	$ -286.28M
Total Liabilities	$ 41.41M	$ 54.68M	$ 49.56M	$ 109.01M	$ 111.75M
Stockholders' Equity	$ ―	$ ―	$ ―	$ ―	$ ―
Cash Flow
Free Cash Flow	$ -102.20M	$ -48.73M	$ -60.74M	$ -149.69M	$ -325.47M
Operating Cash Flow	$ -101.82M	$ -48.73M	$ -58.05M	$ -148.25M	$ -318.63M
Investing Cash Flow
Financing Cash Flow

Medivir AB Earnings and Revenue History

Income Statement >

Medivir AB Debt to Assets

Balance Sheet >

Medivir AB Cash Flow

Cash Flow >

Medivir AB Forecast EPS vs Actual EPS

Earnings >